BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 33071079)

  • 1. Clostridioides difficile infection evaluation and management in the emergency department.
    Carius BM; Liang SY; Koyfman A; Long B
    Am J Emerg Med; 2020 Oct; 38(10):2203-2208. PubMed ID: 33071079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection - An observational cohort study.
    Polivkova S; Krutova M; Capek V; Sykorova B; Benes J
    Int J Infect Dis; 2021 Feb; 103():226-233. PubMed ID: 33188906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic Therapies for Clostridioides difficile Infection in Children.
    Gonzales-Luna AJ; Carlson TJ; Garey KW
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S52-S57. PubMed ID: 34791393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of Treatment Regimens for Clostridioides difficile Infection: An Evaluation of the 2018 Infectious Diseases Society of America Guidelines.
    Rajasingham R; Enns EA; Khoruts A; Vaughn BP
    Clin Infect Dis; 2020 Feb; 70(5):754-762. PubMed ID: 31001619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence.
    Castro-Córdova P; Díaz-Yáñez F; Muñoz-Miralles J; Gil F; Paredes-Sabja D
    Anaerobe; 2020 Apr; 62():102149. PubMed ID: 31940467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fidaxomicin for the treatment of
    Skinner AM; Scardina T; Kociolek LK
    Future Microbiol; 2020 Jul; 15(11):967-979. PubMed ID: 32715754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Navigating changes in
    Durham SH; Le P; Cassano AT
    J Manag Care Spec Pharm; 2020 Dec; 26(12-a Suppl):S3-S23. PubMed ID: 33533699
    [No Abstract]   [Full Text] [Related]  

  • 9. An insight into
    Thabit AK; Aljedaani HJ; Alghamdi RH; Badahdah RM; Lashkar MO; Alnajjar A
    Expert Rev Gastroenterol Hepatol; 2023; 17(8):805-810. PubMed ID: 37480286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes associated with recent guideline recommendations removing metronidazole for treatment of non-severe Clostridioides difficile infection: a retrospective, observational, nationwide cohort study.
    Gentry CA; Campbell DL; Williams RJ
    Int J Antimicrob Agents; 2021 Mar; 57(3):106282. PubMed ID: 33465458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial therapy affects duration of diarrhoea in critically ill patients with Clostridioides difficile infection (CDI).
    Manthey CF; Dranova D; Christner M; Drolz A; Kluge S; Lohse AW; Fuhrmann V
    Crit Care; 2019 Dec; 23(1):399. PubMed ID: 31815650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.
    van Prehn J; Reigadas E; Vogelzang EH; Bouza E; Hristea A; Guery B; Krutova M; Norén T; Allerberger F; Coia JE; Goorhuis A; van Rossen TM; Ooijevaar RE; Burns K; Scharvik Olesen BR; Tschudin-Sutter S; Wilcox MH; Vehreschild MJGT; Fitzpatrick F; Kuijper EJ;
    Clin Microbiol Infect; 2021 Dec; 27 Suppl 2():S1-S21. PubMed ID: 34678515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of adherence to SHEA-IDSA treatment guidelines for Clostridium difficile infection is associated with increased mortality.
    Patel I; Wungjiranirun M; Theethira T; Villafuerte-Galvez J; Castillo N; Akbari M; Alonso CD; Leffler DA; Kelly CP
    J Antimicrob Chemother; 2017 Feb; 72(2):574-581. PubMed ID: 28115504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013-2015.
    Novosad SA; Mu Y; Winston LG; Johnston H; Basiliere E; Olson DM; Farley MM; Revis A; Wilson L; Perlmutter R; Holzbauer SM; Whitten T; Phipps EC; Dumyati GK; Beldavs ZG; Ocampo VLS; Davis CM; Kainer M; Gerding DN; Guh AY
    J Gen Intern Med; 2020 Feb; 35(2):412-419. PubMed ID: 31768906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridioides difficile associated peritonitis in peritoneal dialysis patients - a case series based review of an under-recognized entity with therapeutic challenges.
    Shah KJ; Cherabuddi K; Pressly KB; Wright KL; Shukla A
    BMC Nephrol; 2020 Mar; 21(1):76. PubMed ID: 32131755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, observational study of fidaxomicin use for
    Guery B; Berger P; Gauzit R; Gourdon M; Barbut F; ; Dafne Study Group ; Bémer P; Bessède E; Camou F; Cattoir V; Couzigou C; Descamps D; Dinh A; Laurans C; Lavigne JP; Lechiche C; Leflon-Guibout V; Le Monnier A; Levast M; Mootien JY; N'Guyen Y; Piroth L; Prazuck T; Rogeaux O; Roux AL; Vachée A; Vernet Garnier V; Wallet F
    J Int Med Res; 2021 Jun; 49(6):3000605211021278. PubMed ID: 34162264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Clostridioides difficile infection in adults and challenges in clinical practice: review and comparison of current IDSA/SHEA, ESCMID and ASID guidelines.
    Bishop EJ; Tiruvoipati R
    J Antimicrob Chemother; 2022 Dec; 78(1):21-30. PubMed ID: 36441203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of Clostridioides difficile infections treated in a Swiss tertiary care hospital: an observational study.
    Haubitz S; Bartlomé N; Bucheli Laffer E; Spelters C; Fankhauser H; Fux CA
    Swiss Med Wkly; 2020 Jan; 150():w20173. PubMed ID: 31940431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
    Webb BJ; Subramanian A; Lopansri B; Goodman B; Jones PB; Ferraro J; Stenehjem E; Brown SM
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964789
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clostridioides difficile: updated recommendations].
    Barbut F; Eckert C; Lalande V; Le Neindre K; Couturier J
    Rev Prat; 2022 Sep; 72(7):703-709. PubMed ID: 36511953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.